| Timing of Coronary Artery Bypass Surgery Among Patients With Acute Coronary Syndromes Initially on Ticagrelor (NCT02668562) | Ottawa Heart Institute Research Corporation | 2016-02-01 |
| Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial (NCT02168829) | Ottawa Heart Institute Research Corporation | 2016-01-01 |
| Impact of Preoperative FFR on Arterial Bypass Graft Functionality (NCT02527044) | Ottawa Heart Institute Research Corporation | 2015-11-01 |
| Exercise Training in Patients With Atrial Fibrillation (OPPORTUNITY Study) (NCT02602457) | Ottawa Heart Institute Research Corporation | 2015-11-01 |
| Correlation of the Arrhythmia Mechanism and Substrate to Ablate Persistent Atrial Fibrillation Study (NCT02184013) | Ottawa Heart Institute Research Corporation | 2015-09-14 |
| HYbrid CoronAry Revascularization in DiabeticS (NCT02504762) | Ottawa Heart Institute Research Corporation | 2015-08-01 |
| Utility of a Smart Phone Application in Assessing Radial Artery Patency - the CAPITAL iRADIAL Study (NCT02519491) | Ottawa Heart Institute Research Corporation | 2015-07-01 |
| Biomarkers to Classify Heart Failure (NCT02347722) | Ottawa Heart Institute Research Corporation | 2015-05-01 |
| Augmented Wide Area Circumferential Catheter Ablation for Reduction of Atrial Fibrillation Recurrence (NCT02150902) | Ottawa Heart Institute Research Corporation | 2015-03-01 |
| Autonomic Innervation and MIBG Imaging (NCT02071680) | Ottawa Heart Institute Research Corporation | 2015-03-01 |
| Use of Glidesheath Slender to Reduce Radial Artery Occlusion and Vascular Access Site Complications Following Transradial Coronary Angiography (NCT02324764) | Ottawa Heart Institute Research Corporation | 2014-12-01 |
| A Pilot Study Evaluating Heart and Lung Metabolism in Pulmonary Hypertension Associated With Left Heart Disease (NCT02237378) | Ottawa Heart Institute Research Corporation | 2014-12-01 |
| Cadmium-zinc-telluride (CZT) Imaging of Myocardial Blood Flow (MBF) (SPECT MBF) (NCT02280941) | Ottawa Heart Institute Research Corporation | 2014-10-30 |
| Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention (NCT02114528) | Ottawa Heart Institute Research Corporation | 2014-10-01 |
| A Pharmacodynamic Study of a Personalized Strategy for P2Y12 Inhibition Versus Ticagrelor in Reducing Ischemic and Bleeding Risk (NCT02044146) | Ottawa Heart Institute Research Corporation | 2014-09-01 |
| The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients (NCT02234492) | Ottawa Heart Institute Research Corporation | 2014-09-01 |
| Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation (NCT01994252) | Ottawa Heart Institute Research Corporation | 2014-06-04 |
| Pilot Study to Evaluate Right Ventricular Function With Riociguat in CTEPH (NCT02094001) | Ottawa Heart Institute Research Corporation | 2014-05-01 |
| Cardiac Sarcoidosis Response To Steroids Trial (NCT01210677) | Ottawa Heart Institute Research Corporation | 2014-04-01 |
| CO2 as a Stress Agent for Perfusion Imaging (NCT02043535) | Ottawa Heart Institute Research Corporation | 2014-03-12 |
| Randomized Trial of Nordic Walking vs. Standard Cardiac Rehabilitation in Patients With Heart Failure (NCT02061319) | Ottawa Heart Institute Research Corporation | 2014-03-01 |
| Rubidium Elution System Performance Testing (NCT02117284) | Ottawa Heart Institute Research Corporation | 2014-01-01 |
| Transition From Ticagrelor to Clopidogrel Following Acute Coronary Syndrome: To Bolus or Not? (NCT02054663) | Ottawa Heart Institute Research Corporation | 2013-12-01 |
| 123I-mIBG SPECT Imaging (NCT02043522) | Ottawa Heart Institute Research Corporation | 2013-12-01 |
| The Role of a Motion Sensor With Accompanying Web Application on Step Counts, Energy Balance, and Metabolic Markers in Nurses (NCT04524572) | Ottawa Heart Institute Research Corporation | 2013-11-26 |
| Mild Versus Moderate Therapeutic Hypothermia in Out-of-hospital Cardiac Arrest Patients (NCT02011568) | Ottawa Heart Institute Research Corporation | 2013-08-01 |
| Evaluation of the Ottawa Model for Smoking Cessation in Diabetes Education Programs (NCT01980017) | Ottawa Heart Institute Research Corporation | 2013-07-01 |
| Prognostic Value of Stress SPECT Myocardial Perfusion Imaging With Half Dose 99mTc-Tetrofosmin (NCT02019212) | Ottawa Heart Institute Research Corporation | 2013-06-01 |
| Ticagrelor vs Clopidogrel Effect on MFR in CAD Population (NCT01894789) | Ottawa Heart Institute Research Corporation | 2013-03-01 |
| The Role of Vitamin D in the Pathophysiology of Chronic Failure (NCT01993537) | Ottawa Heart Institute Research Corporation | 2013-01-01 |
| Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events (NCT01675076) | Ottawa Heart Institute Research Corporation | 2013-01-01 |
| The Efficacy and Economics of Exercise Maintenance Post-Cardiac Rehabilitation (NCT01658683) | Ottawa Heart Institute Research Corporation | 2012-10-01 |
| Cardiac Sarcoidosis Multi-Center Prospective Cohort (NCT01477359) | Ottawa Heart Institute Research Corporation | 2012-08-01 |
| ASV Effects on Myocardial Energetics and Sympathetic Nerve Function in Heart Failure and Sleep Apnea. (NCT02116140) | Ottawa Heart Institute Research Corporation | 2012-07-01 |
| A Study of 123I-CMICE-013 Radiopharmaceutical in Healthy Volunteers (NCT01558362) | Ottawa Heart Institute Research Corporation | 2012-04-01 |
| Integrating the "Ottawa Model" for Smoking Cessation Into Primary Care Practice (NCT01603524) | Ottawa Heart Institute Research Corporation | 2012-03-01 |
| Multi-modality Imaging of Ischemia With 18F-FDG PET and CTA (NCT01520025) | Ottawa Heart Institute Research Corporation | 2011-12-01 |
| Reference Population for Speckle Tracking Imaging (NCT01526252) | Ottawa Heart Institute Research Corporation | 2011-12-01 |
| IMAGE-HF: Project IIa Canadian CArdiomyopathy Registry for Device Therapy (NCT04908306) | Ottawa Heart Institute Research Corporation | 2011-10-11 |
| Rhythm Control - Catheter Ablation With or Without Anti-arrhythmic Drug Control of Maintaining Sinus Rhythm Versus Rate Control With Medical Therapy and/or Atrio-ventricular Junction Ablation and Pacemaker Treatment for Atrial Fibrillation (NCT01420393) | Ottawa Heart Institute Research Corporation | 2011-09-01 |
| Pharmacogenetic Approach to Anti-platelet Therapy for the Treatment of ST-segment Elevation Myocardial Infarction (STEMI) (NCT01452139) | Ottawa Heart Institute Research Corporation | 2011-09-01 |
| Femoral Versus Radial Access for Primary PCI (NCT01398254) | Ottawa Heart Institute Research Corporation | 2011-07-01 |
| Study to Develop a Non-invasive Marker for Monitoring Myocardial Fibrosis (NCT01230918) | Ottawa Heart Institute Research Corporation | 2011-05-01 |
| IMAGE-HF Project I-C: Computed Tomographic Coronary Angiography for Heart Failure Patients (NCT01283659) | Ottawa Heart Institute Research Corporation | 2011-02-01 |
| Rt Ventricular Substrate Metabolism as a Predictor of Rt Heart Failure in Patients With Pulmonary Arterial Hypertension (NCT01572077) | Ottawa Heart Institute Research Corporation | 2011-01-01 |
| Routine vs Selective Cardiac Magnetic Resonance in Non-Ischemic Heart Failure (NCT01281384) | Ottawa Heart Institute Research Corporation | 2011-01-01 |
| Self-directed Titrated Transdermal Nicotine Patch Versus Standard Treatment for Smoking Cessation (NCT01622998) | Ottawa Heart Institute Research Corporation | 2011-01-01 |
| IMAGE-HF Project I-A: Cardiac Imaging in Ischemic Heart Failure (AIMI-HF) (NCT01288560) | Ottawa Heart Institute Research Corporation | 2011-01-01 |
| Relation of Carotid Artery Plaque Inflammation, Covert Stroke and White Matter Disease (NCT01236508) | Ottawa Heart Institute Research Corporation | 2010-11-01 |
| ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy Based on GENetic Evaluation (NCT01184300) | Ottawa Heart Institute Research Corporation | 2010-08-01 |
| Reducing Cardiovascular Disease by Combining Smoking Cessation Pharmacotherapy and Behavioural Counseling (NCT01623505) | Ottawa Heart Institute Research Corporation | 2010-06-01 |
| Rubidium-82 - An Alternative Radiopharmaceutical for Myocardial Imaging(Rb-ARMI) (NCT01128023) | Ottawa Heart Institute Research Corporation | 2010-04-01 |
| Accuracy of Half of the Usual Radiotracer Dose in SPECT (NCT01412827) | Ottawa Heart Institute Research Corporation | 2010-04-01 |
| A Study of Caffeine on Cardiac Arrhythmias (NCT02095405) | Ottawa Heart Institute Research Corporation | 2010-02-01 |
| Efficacy and Cost-Effectiveness of Cost-free Pharmacotherapy for Smoking Cessation for High-risk Smokers With Cerebrovascular Disease (NCT00962988) | Ottawa Heart Institute Research Corporation | 2009-12-01 |
| Varenicline Versus Transdermal Nicotine Patch for Smoking Cessation in Patients With Coronary Heart Disease (NCT00959972) | Ottawa Heart Institute Research Corporation | 2009-04-01 |
| Platelet Function Monitoring in Patients Treated With Clopidogrel at the Time of Primary Percutaneous Coronary Angioplasty (NCT00827346) | Ottawa Heart Institute Research Corporation | 2009-01-01 |
| Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial (NCT00800137) | Ottawa Heart Institute Research Corporation | 2008-12-01 |
| Discerning Symptomatic and Asymptomatic Episodes Pre and Post Radiofrequency Ablation of Atrial Fibrillation (NCT00745706) | Ottawa Heart Institute Research Corporation | 2008-09-01 |
| Cost Free Pharmacotherapy for Smoking Cessation in Stroke Patients (NCT01404546) | Ottawa Heart Institute Research Corporation | 2008-08-01 |
| Optimization of SPECT Imaging (NCT01519973) | Ottawa Heart Institute Research Corporation | 2008-08-01 |
| Study to Monitor the Effects of Androgen Suppression Treatment on the Heart (NCT01230905) | Ottawa Heart Institute Research Corporation | 2008-07-01 |
| Family Heart Health Program: Randomized, Controlled Trial (NCT00552591) | Ottawa Heart Institute Research Corporation | 2007-09-01 |
| Prophylactic Intra-coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis (NCT00612521) | Ottawa Heart Institute Research Corporation | 2007-08-01 |
| Cardiac FDG PET Viability Registry (NCT00766987) | Ottawa Heart Institute Research Corporation | 2007-04-01 |
| Transcranial Doppler (TCD) Assessment During Early Anti-thrombotic Therapy After Bioprosthetic Aortic Valve Replacement (NCT00465218) | Ottawa Heart Institute Research Corporation | 2007-03-01 |
| Comparison of Cardiac Computed Tomographic Angiography (CTA) to Tc-99m Single Photon Emission Computed Tomography (SPECT) (NCT00449943) | Ottawa Heart Institute Research Corporation | 2006-09-01 |
| Risk Stratification of Non ST Elevation ACS With Computed Tomographic Angiography (REACT) (NCT00449826) | Ottawa Heart Institute Research Corporation | 2006-09-01 |
| Interactive Voice Response Telephone Technology for the Treatment of Smoking in Patients With Heart Disease (NCT00449852) | Ottawa Heart Institute Research Corporation | 2006-07-01 |
| Trial of Clopidogrel After Surgery for Coronary Artery Disease (CASCADE Trial) (NCT00228423) | Ottawa Heart Institute Research Corporation | 2006-05-01 |
| Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy (NCT00247975) | Ottawa Heart Institute Research Corporation | 2006-03-01 |
| Using Automated Calls To Improve Compliance With Acute Coronary Syndrome Best Practice Guidelines (NCT01151800) | Ottawa Heart Institute Research Corporation | 2006-01-01 |
| A Study of the Effect of Blinding in a Trial of Blood Filtration During Heart Surgery (NCT00246779) | Ottawa Heart Institute Research Corporation | 2005-11-01 |
| The Efficacy and Cost-Effectiveness of Behavioral Counseling for Exercise in Men and Women Following Acute Myocardial Infarction (AMI) and Percutaneous Coronary Intervention (PCI) (NCT00250913) | Ottawa Heart Institute Research Corporation | 2005-08-01 |
| Safety and Efficacy Study of Eptifibatide in Primary Percutaneous Coronary Intervention (PCI) (NCT00251823) | Ottawa Heart Institute Research Corporation | 2005-07-01 |
| CPAP Therapy in Patients With Heart Failure and Obstructive Sleep Apnea. (NCT00756366) | Ottawa Heart Institute Research Corporation | 2005-07-01 |
| A Study Comparing Standard Care for Diabetes to Case-managed Care for Diabetes in Patients With Coronary Artery Disease (NCT00248352) | Ottawa Heart Institute Research Corporation | 2005-02-01 |
| Endothelial Modulation for Angiogenic Therapy (NCT00134433) | Ottawa Heart Institute Research Corporation | 2004-11-01 |
| Evaluation of a Web-based Intervention to Promote Physical Activity in Patients With Heart Disease. (NCT00265525) | Ottawa Heart Institute Research Corporation | 2004-11-01 |
| Resynchronization/Defibrillation for Ambulatory Heart Failure Trial (NCT00251251) | Ottawa Heart Institute Research Corporation | 2003-04-01 |
| PET and Recovery Following Revascularization (PARR 2) (NCT00385242) | Ottawa Heart Institute Research Corporation | 2000-06-01 |